$142.85
-2.92-2%
가까이에: Nov 20, 4:00 PM EST
$142.85
N/A
시간외: Nov 20, 4:26 PM EST

The average analyst price target for Palvella Therapeutics is $179.48, 25.6% above the current price. Of 18 analysts, 18 rate it Buy. Targets range from $38 to $250. The latest change came on Nov 16, 2026, when Leerink Partners initiated coverage of Palvella Therapeutics with an Outperform rating and a $228 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months